PubMed

Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals.

Kakinoki B, Sekimoto S, Yuki S, Ohgami T, Sejima M, Yamagami K, Saito K.

Diabetes. 2006 Mar;55(3):616-21.PMID: 16505223 [PubMed - indexed for MEDLINE]Related articlesFree article

Protection of sensory function in diabetic rats by Neotrofin.

Calcutt NA, Freshwater JD, Hauptmann N, Taylor EM, Mizisin AP.

Eur J Pharmacol. 2006 Mar 18;534(1-3):187-93. Epub 2006 Feb 28.PMID: 16507305 [PubMed - indexed for MEDLINE]Related articles

Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.

Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria G, Magnaghi V, Roglio I, Melcangi RC.

Neuroscience. 2007 Feb 23;144(4):1293-304. Epub 2006 Dec 20.PMID: 17187935 [PubMed - indexed for MEDLINE]Related articles

Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice.

Christianson JA, Riekhof JT, Wright DE.

Exp Neurol. 2003 Feb;179(2):188-99.PMID: 12618126 [PubMed - indexed for MEDLINE]Related articles

A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats.

Riaz S, Malcangio M, Miller M, Tomlinson DR.

Diabetologia. 1999 Nov;42(11):1308-13.PMID: 10550414 [PubMed - indexed for MEDLINE]Related articles

Effect of NGF and neurotrophin-3 treatment on experimental diabetic autonomic neuropathy.

Schmidt RE, Dorsey DA, Beaudet LN, Parvin CA, Escandon E.

J Neuropathol Exp Neurol. 2001 Mar;60(3):263-73.PMID: 11245210 [PubMed - indexed for MEDLINE]Related articles

Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations of the sural nerve, dorsal root ganglion, and spinal cord.

Unger JW, Klitzsch T, Pera S, Reiter R.

Exp Neurol. 1998 Sep;153(1):23-34.PMID: 9743564 [PubMed - indexed for MEDLINE]Related articles

Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors.

Tomlinson DR, Fernyhough P, Diemel LT.

Diabetes. 1997 Sep;46 Suppl 2:S43-9.PMID: 9285498 [PubMed - indexed for MEDLINE]Related articles

Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.

Murakawa Y, Zhang W, Pierson CR, Brismar T, Ostenson CG, Efendic S, Sima AA.

Diabetes Metab Res Rev. 2002 Nov-Dec;18(6):473-83.PMID: 12469361 [PubMed - indexed for MEDLINE]Related articles

Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.

Obrosova IG, Fathallah L, Stevens MJ.

Exp Neurol. 2001 Nov;172(1):211-9.PMID: 11681853 [PubMed - indexed for MEDLINE]Related articles

Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.

Bordet T, Buisson B, Michaud M, Abitbol JL, Marchand F, Grist J, Andriambeloson E, Malcangio M, Pruss RM.

J Pharmacol Exp Ther. 2008 Aug;326(2):623-32. Epub 2008 May 20.PMID: 18492948 [PubMed - indexed for MEDLINE]Related articlesFree article

Nerve growth factor administration protects against experimental diabetic sensory neuropathy.

Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA.

Brain Res. 1994 Jan 14;634(1):7-12.PMID: 7512429 [PubMed - indexed for MEDLINE]Related articles

Talin immunogold density increases in sciatic nerve of diabetic rats after nerve growth factor treatment.

Renno WM, Saleh F, Klepacek I, Al-Awadi F.

Medicina (Kaunas). 2006;42(2):147-63.PMID: 16528132 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia.

Sasaki K, Chancellor MB, Phelan MW, Yokoyama T, Fraser MO, Seki S, Kubo K, Kumon H, Groat WC, Yoshimura N.

J Urol. 2002 Sep;168(3):1259-64.PMID: 12187278 [PubMed - indexed for MEDLINE]Related articles

Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy.

Hellweg R, Hartung HD.

J Neurosci Res. 1990 Jun;26(2):258-67.PMID: 2142224 [PubMed - indexed for MEDLINE]Related articles

Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor.

Ohi T, Saita K, Furukawa S, Ohta M, Hayashi K, Matsukura S.

Exp Neurol. 1998 Jun;151(2):215-20.PMID: 9628756 [PubMed - indexed for MEDLINE]Related articles

Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia.

Schmidt RE, Dorsey DA, Roth KA, Parvin CA, Hounsom L, Tomlinson DR.

Brain Res. 2000 Jun 9;867(1-2):149-56.PMID: 10837808 [PubMed - indexed for MEDLINE]Related articles

Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.

Li F, Szabó C, Pacher P, Southan GJ, Abatan OI, Charniauskaya T, Stevens MJ, Obrosova IG.

Diabetologia. 2004 Apr;47(4):710-7.PMID: 15298348 [PubMed - indexed for MEDLINE]Related articles

Clenbuterol stimulates neurotrophic support in streptozotocin-diabetic rats.

Riaz SS, Tomlinson DR.

Diabetes Obes Metab. 1999 Jan;1(1):43-51.PMID: 11221812 [PubMed - indexed for MEDLINE]Related articles

C-Peptide reverses nociceptive neuropathy in type 1 diabetes.

Kamiya H, Zhang W, Ekberg K, Wahren J, Sima AA.

Diabetes. 2006 Dec;55(12):3581-7.PMID: 17130507 [PubMed - indexed for MEDLINE]Related articlesFree article